HK1092796A1 - Crystal of sulfonamide-containing indole compound and process for producing the same - Google Patents

Crystal of sulfonamide-containing indole compound and process for producing the same

Info

Publication number
HK1092796A1
HK1092796A1 HK06113378.9A HK06113378A HK1092796A1 HK 1092796 A1 HK1092796 A1 HK 1092796A1 HK 06113378 A HK06113378 A HK 06113378A HK 1092796 A1 HK1092796 A1 HK 1092796A1
Authority
HK
Hong Kong
Prior art keywords
sulfonamide
crystal
producing
same
indole compound
Prior art date
Application number
HK06113378.9A
Other languages
English (en)
Inventor
Keiko Takahashi
Kenji Hayashi
Taichi Abe
Takao Omae
Takashi Kato
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of HK1092796A1 publication Critical patent/HK1092796A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06113378.9A 2003-09-10 2006-12-06 Crystal of sulfonamide-containing indole compound and process for producing the same HK1092796A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003318953 2003-09-10
PCT/JP2004/012649 WO2005026118A1 (ja) 2003-09-10 2004-09-01 スルホンアミド含有インドール化合物の結晶およびその製造方法

Publications (1)

Publication Number Publication Date
HK1092796A1 true HK1092796A1 (en) 2007-02-16

Family

ID=34308544

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113378.9A HK1092796A1 (en) 2003-09-10 2006-12-06 Crystal of sulfonamide-containing indole compound and process for producing the same

Country Status (25)

Country Link
US (2) US7754894B2 (zh)
EP (1) EP1666463B1 (zh)
JP (1) JP4435090B2 (zh)
KR (1) KR20060120644A (zh)
CN (2) CN101165049A (zh)
AT (1) ATE486849T1 (zh)
AU (1) AU2004272400B2 (zh)
BR (1) BRPI0414314A (zh)
CA (1) CA2536995C (zh)
CY (1) CY1110975T1 (zh)
DE (1) DE602004029907D1 (zh)
DK (1) DK1666463T3 (zh)
ES (1) ES2354286T3 (zh)
HK (1) HK1092796A1 (zh)
HR (1) HRP20100631T1 (zh)
IL (2) IL174059A0 (zh)
MX (1) MXPA06002732A (zh)
NO (1) NO335256B1 (zh)
NZ (1) NZ546111A (zh)
PL (1) PL1666463T3 (zh)
PT (1) PT1666463E (zh)
RU (1) RU2336269C2 (zh)
SI (1) SI1666463T1 (zh)
TW (1) TW200514770A (zh)
WO (1) WO2005026118A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029907D1 (de) * 2003-09-10 2010-12-16 Eisai R&D Man Co Ltd Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3868534B2 (ja) * 1996-05-24 2007-01-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド誘導体の製造法および中間体
JP2000247949A (ja) * 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
JP4039856B2 (ja) * 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
TWI283575B (en) * 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent
DE602004029907D1 (de) * 2003-09-10 2010-12-16 Eisai R&D Man Co Ltd Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
EP1666463A4 (en) 2007-12-12
JPWO2005026118A1 (ja) 2007-11-08
AU2004272400A1 (en) 2005-03-24
SI1666463T1 (sl) 2011-02-28
MXPA06002732A (es) 2006-06-05
PT1666463E (pt) 2011-01-17
PL1666463T3 (pl) 2011-04-29
BRPI0414314A (pt) 2006-10-31
IL196569A0 (en) 2011-07-31
ATE486849T1 (de) 2010-11-15
CY1110975T1 (el) 2015-06-11
NZ546111A (en) 2008-11-28
KR20060120644A (ko) 2006-11-27
ES2354286T3 (es) 2011-03-11
US20090247768A1 (en) 2009-10-01
US20070082941A1 (en) 2007-04-12
DK1666463T3 (da) 2010-12-20
CA2536995A1 (en) 2005-03-24
CN100406440C (zh) 2008-07-30
DE602004029907D1 (de) 2010-12-16
US7754894B2 (en) 2010-07-13
TWI349663B (zh) 2011-10-01
WO2005026118A1 (ja) 2005-03-24
CA2536995C (en) 2013-12-17
IL174059A0 (en) 2006-08-01
EP1666463B1 (en) 2010-11-03
HRP20100631T1 (hr) 2010-12-31
NO335256B1 (no) 2014-10-27
CN101165049A (zh) 2008-04-23
NO20061545L (no) 2006-06-09
AU2004272400B2 (en) 2010-03-04
RU2336269C2 (ru) 2008-10-20
CN1849305A (zh) 2006-10-18
EP1666463A1 (en) 2006-06-07
RU2006111454A (ru) 2006-08-27
TW200514770A (en) 2005-05-01
JP4435090B2 (ja) 2010-03-17

Similar Documents

Publication Publication Date Title
MY132094A (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
WO2002074758A3 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
HK1077571A1 (en) Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
GEP20104895B (en) Preparation of pregabalin and related compounds
NZ543722A (en) Novel substituted 3-sulfur indoles
HK1067129A1 (en) A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
GEP20105036B (en) Perindopril
EP1790634A3 (en) Fluvastatin sodium crystal form and processes for preparing it
AU2003261940A8 (en) Acicular silicon crystal and process for producing the same
AU2003274462A1 (en) N-(indole-2-carbonyl) amides as anti-diabetic agents
MY138826A (en) 2,7-substituted indoles
HK1092796A1 (en) Crystal of sulfonamide-containing indole compound and process for producing the same
WO2005005461A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
GEP20074257B (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY135169A (en) NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MY135652A (en) NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-PERHYDROINDOLE-2-CARBOXYLIC ACID AND ESTERS THEREOF, AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL
WO2005012328A3 (fr) Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
AU2003260942A8 (en) A process for the preparation of oxindole derivatives
GEP20094740B (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170901